Blacks, Hispanics Have Increased Adenoma Prevalence

This article originally appeared here.
Share this content:

(HealthDay News) – Compared to whites, Hispanic and black patients have an increased prevalence of adenomas and an increased risk of advanced adenomas, according to a study published in the June issue of Alimentary Pharmacology & Therapeutics.

In an effort to determine the prevalence of adenomas among whites, blacks, and Hispanics, Benjamin Lebwohl, MD, of the Columbia University Medical Center in New York City, and colleagues reviewed data from the electronic medical records of 5,075 patients aged 50 years or older undergoing first-time colonoscopy since 2006.

The researchers found that at least one adenoma was detected in 19% of 3,542 whites, 22% of 942 Hispanics, and 26% of 591 blacks (Hispanics versus whites P=0.09; blacks versus whites P=0.0001). A higher rate of adenomas was seen in Hispanics and blacks vs. whites (relative risk, 1.37 and 1.76, respectively). There was also an increased risk of advanced adenomas in Hispanics and blacks vs. whites (odds ratioHispanics, 2.25; and odds ratioblacks, 1.91)

"Adenoma prevalence was higher in blacks and Hispanics than that in whites," the authors write. "Both groups were at greater risk of having proximal adenomas in the absence of any distal pathology than whites, where these lesions would have only been detected by colonoscopy."

Full Text (subscription or payment may be required)

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs